Lindsey Roeker, MD, CLL Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, outlines her ASH 2020 presentation on a worldwide study examining the outcomes for patients with chronic lymphocytic leukemia (CLL) and COVID-19. The study found that patients with CLL hospitalized for COVID-19 had a case fatality rate of 30-34% and advanced patient age at the time of COVID-19 diagnosis was an independent predictor for overall survival. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.